109 related articles for article (PubMed ID: 9643558)
1. Enhancement of adenovirus-mediated gene transfer to human bone marrow cells.
Watanabe T; Kelsey L; Ageitos A; Kuszynski C; Ino K; Heimann DG; Varney MT; Shepard HM; Vaillancourt MT; Maneval DC; Talmadge JE
Leuk Lymphoma; 1998 May; 29(5-6):439-51. PubMed ID: 9643558
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors.
Watanabe T; Kuszynski C; Ino K; Heimann DG; Shepard HM; Yasui Y; Maneval DC; Talmadge JE
Blood; 1996 Jun; 87(12):5032-9. PubMed ID: 8652816
[TBL] [Abstract][Full Text] [Related]
3. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors.
Neering SJ; Hardy SF; Minamoto D; Spratt SK; Jordan CT
Blood; 1996 Aug; 88(4):1147-55. PubMed ID: 8695831
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging.
Seth P; Brinkmann U; Schwartz GN; Katayose D; Gress R; Pastan Ira ; Cowan K
Cancer Res; 1996 Mar; 56(6):1346-51. PubMed ID: 8640824
[TBL] [Abstract][Full Text] [Related]
5. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
6. Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood.
Campain JA; Terrell KL; Tomczak JA; Shpall EJ; Hami LS; Harrison GS
Biol Blood Marrow Transplant; 1997 Nov; 3(5):273-81. PubMed ID: 9450923
[TBL] [Abstract][Full Text] [Related]
7. Poly-L-lysine-based molecular conjugate vectors: a high efficiency gene transfer system for human progenitor and leukemia cells.
Schwarzenberger P; Huang W; Oliver P; Osidipe T; Theodossiou C; Kolls JK
Am J Med Sci; 2001 Feb; 321(2):129-36. PubMed ID: 11217815
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells.
Hirai M; LaFace D; Robinson S; Kelsey L; Johnson R; Wen SF; Warkentin P; Mills K; Vaillancourt M; Chavez J; Leutzinger C; Sumegi J; Neugebauer S; Lehman J; Talmadge C; Maneval D; Talmadge J
Cancer Gene Ther; 2001 Dec; 8(12):936-47. PubMed ID: 11781656
[TBL] [Abstract][Full Text] [Related]
9. High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors.
Frey BM; Hackett NR; Bergelson JM; Finberg R; Crystal RG; Moore MA; Rafii S
Blood; 1998 Apr; 91(8):2781-92. PubMed ID: 9531588
[TBL] [Abstract][Full Text] [Related]
10. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector.
Hersh J; Crystal RG; Bewig B
Gene Ther; 1995 Mar; 2(2):124-31. PubMed ID: 7719929
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vector-based purging of multiple myeloma cells.
Teoh G; Chen L; Urashima M; Tai YT; Celi LA; Chen D; Chauhan D; Ogata A; Finberg RW; Webb IJ; Kufe DW; Anderson KC
Blood; 1998 Dec; 92(12):4591-601. PubMed ID: 9845525
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A
J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765
[TBL] [Abstract][Full Text] [Related]
13. In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia.
Johnson LG; Pickles RJ; Boyles SE; Morris JC; Ye H; Zhou Z; Olsen JC; Boucher RC
Hum Gene Ther; 1996 Jan; 7(1):51-9. PubMed ID: 8825868
[TBL] [Abstract][Full Text] [Related]
14. Efficient gene transfer into T lymphocytes by fiber-modified human adenovirus 5.
Lv Y; Xiao FJ; Wang Y; Zou XH; Wang H; Wang HY; Wang LS; Lu ZZ
BMC Biotechnol; 2019 Apr; 19(1):23. PubMed ID: 31014302
[TBL] [Abstract][Full Text] [Related]
15. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
16. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.
Chen L; Pulsipher M; Chen D; Sieff C; Elias A; Fine HA; Kufe DW
J Clin Invest; 1996 Dec; 98(11):2539-48. PubMed ID: 8958216
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
Shields LE; Kiem HP; Andrews RG
Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
[TBL] [Abstract][Full Text] [Related]
18. Increased transduction efficiency of primary hematopoietic cells by physical colocalization of retrovirus and target cells.
Hutchings M; Moriwaki K; Dilloo D; Hoffmann T; Kimbrough S; Johnsen HE; Brenner MK; Heslop HE
J Hematother; 1998 Jun; 7(3):217-24. PubMed ID: 9621255
[TBL] [Abstract][Full Text] [Related]
19. Umbilical cord blood cell transduction by retroviral vectors: preclinical studies to optimize gene transfer.
Hanley ME; Nolta JA; Parkman R; Kohn DB
Blood Cells; 1994; 20(2-3):539-43; discussion 544-6. PubMed ID: 7538356
[TBL] [Abstract][Full Text] [Related]
20. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
